Personal information

Activities

Collapse all

Employment (4)

Mental Health Centre Northern Zealand, Mental Health Services of the Capital Region: Hillerød, DK: Hillerød, DK

2019-12-01 to present | Head of Inpatient Clinic and Chief Physician (Department of Adult Psychiatry)
Employment
Source: Self-asserted source
Bodil Aggernæs

University of Copenhagen/Psychiatry Region Zealand: Roskilde, Region Zealand, DK

2015-10-01 to 2019-12-01 | Associate professor of clinical research, Senior consultant (Department of Clinical Medicine/Department of Child and Adolescent Psychiatry)
Employment
Source: Self-asserted source
Bodil Aggernæs

University of Copenhagen: Copenhagen, DK

2011 to 2016 | Associate professor of Child and Adolescent Psychiatry, postgraduate (Department of Clinical Medicine)
Employment
Source: Self-asserted source
Bodil Aggernæs

Child and Adolescent Mental Health Center, Capital Region Psychiatry: Copenhagen, DK

2013 to 2015 | Head of the Outpatient Clinic for Preschool Children B192 and Chief Physician (Bispebjerg Department)
Employment
Source: Self-asserted source
Bodil Aggernæs

Education and qualifications (4)

University of Copenhagen Copenhagen, The Faculty of Health Sciences DK: Copenhagen, DK

2010 | Specialist of Child and Adolescent Psychiatry (Child and Adolescent Mental Health Center, Mental Health Services of the Capital Region)
Qualification
Source: Self-asserted source
Bodil Aggernæs

University of Copenhagen: Copenhagen, DK

2005 to 2009 | PhD (Faculty of Health Sciences)
Education
Source: Self-asserted source
Bodil Aggernæs

University of Copenhagen: Copenhagen, DK

1987-08 to 1995-01 | MD (Faculty of Health Sciences)
Education
Source: Self-asserted source
Bodil Aggernæs

University of Copenhagen: Copenhagen, DK

1983-08-01 to 1987-08-01 | Student (Institute of Ethnography and Social Antropology)
Qualification
Source: Self-asserted source
Bodil Aggernæs

Professional activities (3)

Danish Society of Psychiatry: Copenhagen, DK

2008 to present
Membership
Source: Self-asserted source
Bodil Aggernæs

Federation of European Neuroscience Societies: Copenhagen, DK

2007 to present
Membership
Source: Self-asserted source
Bodil Aggernæs

Danish Society of Child and Adolescent Psychiatry: Copenhagen, DK

2005 to present
Membership
Source: Self-asserted source
Bodil Aggernæs

Works (21)

Suggestion of a dynamic model of the development of neurodevelopmental disorders and the phenomenon of autism

AIMS Molecular Science
2020-05-29 | Journal article
DOI: 10.3934/molsci.2020008
Source: Self-asserted source
Bodil Aggernæs

Autism: a transdiagnostic, dimensional, construct of reasoning?

European Journal of Neuroscience
2018 | Journal article
DOI: 10.1111/ejn.13599
EID:

2-s2.0-85019965957
Contributors: Aggernæs, B.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy

Psychological Medicine
2017 | Journal article
DOI: 10.1017/S0033291717000599
EID:

2-s2.0-85018360654
Contributors: Oranje, B.; Aggernaes, B.; Rasmussen, H.; Ebdrup, B.H.; Glenthoj, B.Y.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Rethinking the Concept of Psychosis and the Link Between Autism and Schizophrenia

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
2016 | Journal article
DOI: 10.21307/sjcapp-2016-002
Contributors: Bodil Aggernæs
Source: Self-asserted source
Bodil Aggernæs via Crossref Metadata Search

Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients

International Journal of Neuropsychopharmacology
2013 | Journal article
DOI: 10.1017/S1461145712001253
EID:

2-s2.0-84878887293
Contributors: Nejad, A.B.; Madsen, K.H.; Ebdrup, B.H.; Siebner, H.R.; Rasmussen, H.; Aggernæs, B.; Glenthoj, B.Y.; Baaré, W.F.C.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophrenia

Journal of Clinical Psychopharmacology
2013 | Journal article
DOI: 10.1097/JCP.0b013e318287acc9
EID:

2-s2.0-84874930019
Contributors: Rasmussen, H.; Ebdrup, B.H.; Aggernaes, B.; Lublin, H.; Oranje, B.; Pinborg, L.H.; Knudsen, G.M.; Glenthøj, B.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

P50 suppression and its neural generators in antipsychotic-Naïve first-episode schizophrenia before and after 6 months of quetiapine treatment

Schizophrenia Bulletin
2013 | Journal article
DOI: 10.1093/schbul/sbr183
EID:

2-s2.0-84874533482
Contributors: Oranje, B.; Aggernaes, B.; Rasmussen, H.; Ebdrup, B.H.; Glenthøj, B.Y.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Structural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia

Journal of Psychiatry and Neuroscience
2013 | Journal article
DOI: 10.1503/jpn.110129
EID:

2-s2.0-84871553342
Contributors: Hammer, T.B.; Oranje, B.; Skimminge, A.; Aggernæs, B.; Ebdrup, B.H.; Glenthøj, B.; Baaré, W.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients

European Psychiatry
2013 | Journal article
DOI: 10.1016/j.eurpsy.2012.06.003
EID:

2-s2.0-84880756676
Contributors: Andersen, R.; Fagerlund, B.; Rasmussen, H.; Ebdrup, B.H.; Aggernaes, B.; Gade, A.; Oranje, B.; Glenthoj, B.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Poster #34 WORKING MEMORY-RELATED BRAIN ACTIVITY IN ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIA PATIENTS AFTER SEVEN MONTHS OF QUETIAPINE TREATMENT

Schizophrenia Research
2012-04 | Journal article
DOI: 10.1016/s0920-9964(12)70606-0
Contributors: Avna B. Nejad; Björn H. Ebdrup; Hans Rasmussen; Bodil Aggernæs; William F.C. Baaré; Hartwig R. Siebner; Bine Y. Glenthøj
Source: Self-asserted source
Bodil Aggernæs via Crossref Metadata Search

Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophrenia

Psychiatry Research
2011 | Journal article
DOI: 10.1016/j.psychres.2010.10.013
EID:

2-s2.0-79953081209
Contributors: Andersen, R.; Fagerlund, B.; Rasmussen, H.; Ebdrup, B.H.; Aggernaes, B.; Gade, A.; Oranje, B.; Glenthoj, B.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Impaired temporoparietal deactivation with working memory load in antipsychotic-naÃve patients with first-episode schizophrenia

World Journal of Biological Psychiatry
2011 | Journal article
DOI: 10.3109/15622975.2010.556199
EID:

2-s2.0-79955822442
Contributors: Nejad, A.B.; Ebdrup, B.H.; Siebner, H.R.; Rasmussen, H.; Aggernæs, B.; Glenthøj, B.Y.; Baarée, W.F.C.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: Relationship to dose and symptoms

International Journal of Neuropsychopharmacology
2011 | Journal article
DOI: 10.1017/S1461145710000817
EID:

2-s2.0-79952743198
Contributors: Ebdrup, B.H.; Skimminge, A.; Rasmussen, H.; Aggernaes, B.; Oranje, B.; Lublin, H.; Baaré, W.; Glenthøj, B.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine

Psychopharmacology
2011 | Journal article
DOI: 10.1007/s00213-010-1941-5
EID:

2-s2.0-79952487695
Contributors: Rasmussen, H.; Ebdrup, B.H.; Erritzoe, D.; Aggernaes, B.; Oranje, B.; Kalbitzer, J.; Pinborg, L.H.; Baaré, W.F.C.; Svarer, C.; Lublin, H. et al.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Decreased frontal serotonin<inf>2A</inf> receptor binding in antipsychotic-naive patients with first-episode schizophrenia

Archives of General Psychiatry
2010 | Journal article
DOI: 10.1001/archgenpsychiatry.2009.176
EID:

2-s2.0-73649110630
Contributors: Rasmussen, H.; Erritzoe, D.; Andersen, R.; Ebdrup, B.H.; Aggernaes, B.; Oranje, B.; Kalbitzer, J.; Madsen, J.; Pinborg, L.H.; Baaré, W. et al.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia

Journal of Psychiatry and Neuroscience
2010 | Journal article
DOI: 10.1503/jpn.090049
EID:

2-s2.0-77649280648
Contributors: Ebdrup, B.H.; Glenthøj, B.; Rasmussen, H.; Aggernaes, B.; Langkilde, A.R.; Paulson, O.B.; Lublin, H.; Skimminge, A.; Baaré, W.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine

International Journal of Neuropsychopharmacology
2010 | Journal article
DOI: 10.1017/S1461145710000787
EID:

2-s2.0-79952669970
Contributors: Aggernaes, B.; Glenthoj, B.Y.; Ebdrup, B.H.; Rasmussen, H.; Lublin, H.; Oranje, B.
Source: Self-asserted source
Bodil Aggernæs via Scopus - Elsevier

COGNITIVE DEFICITS IN FIRST-EPISODE ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIC PATIENTS

Schizophrenia Research
2010-04 | Journal article
DOI: 10.1016/j.schres.2010.02.281
Contributors: Rune Andersen; Birgitte Fagerlund; Bob Oranje; Anders Gade; Hans Rasmussen; Bjørn Ebdrup; Bodil Aggernæs; Birte Glenthøj
Source: Self-asserted source
Bodil Aggernæs via Crossref Metadata Search

REGIONAL BRAIN CHANGES IN INITIALLY ANTIPSYCHOTIC-NAïVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS TREATED WITH QUETIAPINE: RELATION TO DOSE AND PSYCHOPATHOLOGY

Schizophrenia Research
2010-04 | Journal article
DOI: 10.1016/j.schres.2010.02.327
Contributors: Bjørn H. Ebdrup; Arnold Skimminge; Hans Rasmussen; Bodil Aggernaes; Bob Oranje; Henrik Lublin; William Baaré; Birte Glenthoj
Source: Self-asserted source
Bodil Aggernæs via Crossref Metadata Search

SEROTONIN2A RECEPTOR BLOCKADE AND CLINICAL EFFECT IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS TREATED WITH QUETIAPINE

Schizophrenia Research
2010-04 | Journal article
DOI: 10.1016/j.schres.2010.02.944
Contributors: Hans Rasmussen; Bjorn H. Ebdrup; David Erritzoe; Bodil Aggernaes; Bob Oranje; Jan Kalbitzer; Lars H. Pinborg; William Baaré; Claus Svarer; Henrik Lublin et al.
Source: Self-asserted source
Bodil Aggernæs via Crossref Metadata Search

P50 SUPPRESSION IN FIRST-EPISODE, ANTIPSYCHOTIC-NAÏVE SCHIZOPHRENIC PATIENTS. A LONGITUDINAL STUDY

Schizophrenia Research
2008-06 | Journal article
DOI: 10.1016/s0920-9964(08)70070-7
Contributors: Bodil Aggernaes; Bob Oranje; Birte Glenthoj
Source: Self-asserted source
Bodil Aggernæs via Crossref Metadata Search
How many people are using ORCID?